InsidersTradesSigma
Track the ASCENTAGE PHARMA GROUP INTERNATIONAL stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was disclosed on 22 May 2026 (Levée d'options). Among the most active insiders: Yang Dajun. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
ASCENTAGE PHARMA GROUP INTERNATIONAL is a company focused on developing innovative pharmaceutical solutions. It operates on the XNAS stock market.